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Summary 
Asthma is a common chronic condition of the airways, associated with episodes of wheezing, 
breathlessness, chest tightness and cough. Hospitalisation for asthma is rarely required as 
most symptoms are managed in the community through medication use and primary health 
care interventions. However, in cases where asthma exacerbations cannot be managed at 
home, hospitalisation may be required. This report provides an overview of these asthma 
hospitalisation patterns over time and across population groups.  
In 2010–11 there were 37,830 hospitalisations where asthma was the principal diagnosis. The 
asthma hospitalisation rate (175 per 100,000 population) is low compared with other 
countries.  
Hospitalisation for asthma decreased between 1998–99 and 2010–11. There was an overall 
reduction in the rate of hospitalisation for asthma among both children (33%) and adults 
(45%).  
Asthma hospitalisation rates varied across population groups in 2010–11: 
• The rate for Indigenous Australians was 2.1 times the rate for Other Australians.  
• Among adults, rates were higher in areas that were more remote (83 per 100,000 
population in Major cities and 214 per 100,000 in Very remote regions). This pattern was 
reversed among children, where rates were lower in areas that were more remote (511 
per 100,000 in Major cities and 404 per 100,000 in Very remote regions).  
• Rates were higher among people living in areas with the lowest socioeconomic status 
(209 per 100,000 population) than for those living in areas with the highest 
socioeconomic status (134 per 100,000 population).  
• Rates for people born in a non-English-speaking country were lower than for those born 
in an English-speaking country, with the exception of those aged over 65, where the rates 
were higher.  
Children had higher rates of hospitalisation for asthma than adults (495 compared with 92 
per 100,000 population) although adults tended to stay in hospital for asthma longer than 
children: on average, 2.9 days compared with 1.5 days. 
One in four people hospitalised with a principal diagnosis of asthma in 2010–11 had an acute 
respiratory infection recorded as an additional diagnosis. 
Direct health expenditure for asthma was $655 million in 2008–09. The pattern of 
expenditure on asthma differs somewhat from the pattern for diseases overall. Half (50%) of 
all asthma expenditure in 2008–09 was attributed to prescription pharmaceuticals, 
(compared to 14% across all diseases) and a substantially lower proportion of asthma 
expenditure was attributed to admitted patient hospital care (20%), compared with total 
recurrent health expenditure across all diseases (52%). 
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1 Introduction 
Asthma is a chronic inflammatory condition of the airways, associated with episodes of 
wheezing, breathlessness, chest tightness and cough. These episodes can be triggered by 
viral infections, exercise, air pollutants, tobacco smoke or exposure to allergens such as 
house dust mites, pollens and mould spores.  
Asthma is a common condition, affecting one in ten Australians (ABS 2012). It affects certain 
subsections of the population at a higher rate. Asthma prevalence appears to be higher 
among Aboriginal or Torres Strait Islanders, and among those living in areas of lower 
socioeconomic status. Asthma prevalence appears to be higher in Inner regional areas than in 
Major cities (ACAM 2011).  
Most people who live with asthma will not require hospitalisation in a given year as 
symptoms can generally be managed through medication use and primary health care 
interventions. However, hospitalisation may be required when exacerbations cannot be 
managed in the community.  
The rate of hospitalisation among people with asthma in Australia is low compared with 
other countries. An Australian study found that 3.8% of adults and 4.9% of children with 
asthma were hospitalised for the condition in the past 12 months (Marks et al. 2007). This 
was lower than the rates reported in the Global Asthma Insights and Reality surveys 
conducted in North America, Europe and Asia, where rates ranged from 7.0% for western 
Europe to 19.1% for central and eastern Europe (Rabe et al. 2004).  
This report presents information about asthma hospitalisations in Australia in 2010–11 and 
looks at how asthma hospitalisation rates vary across different population groups and over 
time (for the period 1998–99 to 2010–11). Asthma hospitalisation patterns for various 
population groups are also compared with overall hospitalisation patterns, to shed light on 
whether variations appear peculiar to asthma or instead could be due to broader factors 
relating to hospitalisation generally.  
In order to shed light on the most severe, life-threatening hospital admissions for asthma, 
information is provided about invasive mechanical ventilation, an intervention needed when 
the patient can no longer breathe independently.  
Information is also presented on the conditions that commonly coincide with asthma for 
hospitalised patients, and on health expenditure related to asthma. 
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2 Hospitalisations for asthma 
Hospitalisation for asthma is necessary when asthma exacerbations are life-threatening or 
cannot be managed at home or in a primary health care setting. 
There are a number of factors that will contribute to hospitalisation rates: 
• asthma prevalence (the total number of cases of asthma that exist in the community)   
• appropriateness of asthma management 
• access to primary health care and hospital alternatives 
• admission practices (that is, hospital decisions about whether to admit patients or treat 
them as non-admitted patients) 
• the presence of comorbidities that complicate the management of the disease and 
increase the likelihood of hospitalisation for asthma. 
Hospitalisation data 
This report presents information about asthma hospitalisations, drawn from the National 
Hospital Morbidity Database (NHMD), a comprehensive dataset that has records for all 
episodes of admitted patient care from essentially all public and private hospitals in 
Australia. The NHMD includes information about ‘hospital separations’ (Box 1).  
This report primarily looks at hospital separations where asthma was the principal 
diagnosis. The principal diagnosis is the diagnosis established, after study, to be chiefly 
responsible for occasioning the patient’s episode of admitted patient care.  
Additional information about the methods and data sources used in this report is presented 
in Appendix A. 
Box 1: Hospital separations  
A ‘hospital separation’ is the term used to refer to an episode of admitted patient care, 
which can be a total hospital stay (from admission to discharge, transfer or death) or a 
portion of a hospital stay beginning or ending in a change of type of care (for example, from 
acute care to rehabilitation) (AIHW 2012). In this report the terms ‘hospitalisation’ and 
‘hospital separation’ are used interchangeably. 
Hospitalisations in 2010–11 
In 2010–11 there were 37,830 hospitalisations where asthma was the principal diagnosis. The 
overall rate of hospital separation for asthma was 175 per 100,000 population. The rate 
among children aged 0–14 (495 per 100,000 population) was much higher than the rate 
among people aged 15 and over (92 per 100,000 population). 
The average length of hospital stay among people hospitalised with asthma was 2.1 days in 
2010–11. On average, people aged 15 and over tended to stay in hospital longer (2.9 days) 
than children aged 0–14 (1.5 days).  
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Population subgroups 
Age and sex 
In 2010–11 the highest rate of hospital separations for asthma was observed in children aged 
0–4, and was much higher for boys in this age group (1,230 per 100,000 population) than for 
girls (673 per 100,000 population) (Figure 2.1, Appendix table B.1). Boys were also 
hospitalised for asthma at a higher rate than girls in the 5–14 age group. For persons aged 
over 15, this trend reversed, with higher hospitalisation rates for women than for men. This 
result is consistent with the higher prevalence of asthma among boys than girls and the 
higher prevalence of asthma among women than men, based on self-reported data from the 
Australian Bureau of Statistics (ABS) National Health Survey (NHS) (ACAM 2011, ABS 
2009a). The reasons for these sex differences remain unexplained.  
 
Notes 
1. Age-standardised to the Australian population as at 30 June 2001. 
2. Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases and Related 
Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 7th edition (NCCH 2010a). The codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 2.1: Hospital separations for asthma per 100,000 population, 2010–11 
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Compared with the general hospitalised population, those hospitalised for asthma are much 
younger. In 2010–11, more than half (57%) of all hospital separations for asthma were for 
children aged 0–14 (Figure 2.2). The proportion of all-cause hospital separations for children 
aged 0–14 was only 7%. In contrast, a much smaller proportion of people hospitalised for 
asthma were aged 65 and over, compared with those who were hospitalised for all causes 
(9% versus 38%, respectively). 
 
Note:  Asthma separations relate to separations where asthma was the principal diagnosis. Asthma was classified according to the 
          International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM),  
          7th edition (NCCH 2010a). The codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 2.2: Age distribution for hospital separations for asthma and all causes, 2010–11 
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Socioeconomic status 
Socioeconomic status (SES) gives an indication of how ‘well off’ a person or group is. SES 
takes into account people’s access to material and social resources as well as their ability to 
participate in society. 
The NHMD includes data on the patient’s area of usual residence and the SES of the area can 
be estimated using a score based on the Index of Relative Socio-economic Disadvantage 
(IRSD) developed by the Australian Bureau of Statistics (ABS 2006a). The SES score is 
divided into five groups, from the lowest (‘worst off’) to the highest SES (‘best off’). For more 
information, see Appendix A, Section A.3. 
People living in areas with lower SES were hospitalised for asthma at a higher rate than 
those living in areas of higher SES (Figure 2.3). This trend was observed for all age groups 
although was more noticeable in the younger age groups. Overall, the rate of hospital 
separations for asthma was higher among those residing in areas with the lowest SES (209 
per 100,000 population) compared with those residing in areas with the highest SES (134 per 
100,000 population).  
For all-cause hospitalisations, there was a small increase in the hospitalisation rates for 
people living in areas with the lowest SES, compared with those living in other areas (AIHW 
2012). The association between the SES of residence and hospitalisation rates therefore 
appears to be similar, or stronger, for asthma than for hospitalisations overall.  
 
Notes 
1. Age-standardised to the Australian population as at 30 June 2001.  
2. SES refers to socioeconomic status (see Appendix A, Section A.3). 
3. Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases and Related 
Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 7th edition (NCCH 2010a). The codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 2.3: Hospital separations for asthma per 100,000 population, by socioeconomic status, 
2010–11 
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Cities, regions and remote areas 
In 2010–11, children aged 0–14 living in Major cities had a higher hospitalisation rate for 
asthma than those living in Very remote areas (511 per 100,000 population in Major cities and 
404 per 100,000 in Very remote areas). In contrast, for people aged 15 and over, the 
hospitalisation rate for asthma was higher in Very remote areas than in Major cities (214 per 
100,000 in Very remote areas and 83 per 100,000 in Major cities) (Figure 2.4). For all-cause 
hospitalisations, the hospitalisation rate was highest in Very remote areas for both age groups 
(Figure 2.4). (See Appendix A, Section A.3, for further information about assignment of 
remoteness areas to hospital data).  
 
Notes 
1. Age-standardised to the Australian population as at 30 June 2001.  
2. Asthma hospital separations relate to separations where asthma was the principal diagnosis. Asthma was classified according to the 
International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 7th 
edition (NCCH 2010a). The codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 2.4: Hospital separations for asthma and all causes per 100,000 population, by remoteness, 
2010–11 
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The average length of stay in hospital for asthma was longer for children (aged 0–14) 
residing in Very remote areas (1.8 days) than in Major cities (1.5 days). The opposite trend was 
observed for adults (aged 15+) where the average length of stay was shorter for those 
residing in Very remote areas (2.5 days) compared to those residing in Major cities (3.0 days).  
Indigenous Australians 
The asthma hospitalisation rate for Indigenous Australians was 2.1 times the rate for Other 
Australians in 2010–11.  
Among both Indigenous Australians and Other Australians, the hospitalisation rate for 
asthma was highest in children aged 0–4 (Figure 2.5, Appendix table B.3). The asthma 
hospitalisation rate was very similar for Indigenous Australians and Other Australians in 
this age group.  
Over the age of 5, Indigenous Australians had consistently higher rates of hospitalisation for 
asthma than Other Australians. This difference was greatest in those aged 35 and over. The 
asthma hospitalisation rate among Indigenous Australians compared with Other Australians 
was 5.4 times higher in the 35–54 age group and 3.2 times higher in the 55 and over age 
group.  
For all-cause hospitalisations, higher hospitalisation rates were observed among Indigenous 
Australians than Other Australians across all age groups except for children aged 5–14, 
where the hospitalisation rates were similar (AIHW 2012). 
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Notes 
1. Age-standardised to the Australian population as at 30 June 2001. See Appendix table B.4 for the raw numbers. 
2. Other Australians include people classified as non-Indigenous plus those for whom Indigenous status was not reported. Indigenous status 
was not reported in 1.2% of hospital separations in the Other Australians category. For more information on Indigenous identification data 
see Appendix A, Section A.2. 
3. Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases and Related 
Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 7th edition (NCCH 2010a). The codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 2.5: Hospital separations for asthma per 100,000 population, by Indigenous status, 2010–11 
The average length of stay in hospital for asthma was 2.0 days for Indigenous Australians 
and 2.1 days for Other Australians.  
Country of birth 
In all age groups, except for those aged 65 and over, the asthma hospitalisation rate was 
higher among those born in English-speaking countries than among those born in non-
English-speaking countries. For those aged 65 and over this pattern was reversed, although 
the difference in the hospitalisation rate was small (Figure 2.6) (See Appendix A, Section A.3 
for further details about the country of birth analysis).  
All-cause hospitalisation rates show a different pattern by country of birth, for all age groups 
except the 35–64 age group (Figure 2.6). This suggests that the variation in asthma 
hospitalisation rates by country of birth is caused by factors specific to asthma.  
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Notes 
1. Age-standardised to the Australian population as at 30 June 2001.  
2. English-speaking countries cover Australia, New Zealand, Canada, United Kingdom, Ireland, United States of America, South Africa and 
Zimbabwe. Non-English-speaking countries cover all other countries. See Appendix A, Section A.3 for further information. 
3. Information was not presented for ages 0–5 due to small numbers.  
4. Asthma hospital separations relate to separations where asthma was the principal diagnosis. Asthma was classified according to the 
International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 7th 
edition (NCCH 2010a). The codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 2.6: Hospital separations for asthma and all causes per 100,000 population, by country of 
birth, 2010–11 
0
50
100
150
200
250
300
5–14 15–34 35–64 65 and over
Age group (years) 
English-speaking country of birth
Non-English-speaking country of birth
Asthma hospital separations per 100,000 population 
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000
5–14 15–34 35–64 65 and over
Age group (years) 
English-speaking country of birth
Non-English-speaking country of birth
All cause hospital separations per 100,000 population 
 10 Asthma hospitalisations in Australia 2010–11 
Trends over time 
Asthma hospitalisation 
There was a substantial reduction in the age-standardised hospitalisation rate for asthma in 
both adults (45%) and children (33%) between 1998–99 and 2010–11 (Figure 2.7, Appendix 
table B.2). 
The time trends in rates of hospitalisation for asthma differed from the time trends for all-
cause hospitalisations over the same period. Between 1998–99 and 2010–11, all-cause 
hospitalisations among children remained relatively stable (a decrease of 2%), while among 
adults the rate increased over time (an increase of 26%). This suggests that the trends in 
asthma hospitalisation are not merely responding to factors that affect all hospitalisations. 
A decrease in the prevalence of asthma over this time period may have played a role in the 
decrease in asthma hospitalisations. According to National Health Survey (NHS) data, 
collected by the Australian Bureau of Statistics (ABS), over the time period 2001 to 2007–08, 
the prevalence of asthma declined among adults by 11% and among children by 27% 
(ACAM 2011, ABS 2003, ABS 2006b, ABS 2009a).  
There are several other factors that may have contributed to the decrease in asthma 
hospitalisations. Over this time period it is possible that there were improvements in long-
term or preventive management of asthma or more effective out-of-hospital management of 
disease exacerbations. There may have been changes in admission practices, or a decrease in 
the severity of asthma over this period. It is not possible to attribute the decrease in asthma 
hospitalisations to any of these factors with certainty. 
  Asthma hospitalisations in Australia 2010–11 11 
 
 
Notes 
1. Age-standardised to the Australian population as at 30 June 2001.  
2. Asthma hospital separations relate to separations where asthma was the principal diagnosis. Asthma was classified according to the 
International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM) 7
th
 
edition (NCCH 2010a) for 2010–11, and earlier editions were used for the years 1998–99 to 2009–10. In all editions of ICD-10-AM used, the 
codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 2.7: Hospital separations for asthma and all causes per 100,000 population, 1998–99 to 
2010–11 
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Length of hospital stay 
Trends in the length of stay in hospital may provide information about disease severity. It is 
also possible that the trends may reflect changes in hospital admission and discharge policies 
and practices over time. 
Among adults, the average length of hospital stay declined between 1998–99 and 2010–11, 
both for asthma and for all causes. Among children, the average length of stay for asthma 
decreased after 1998–99 in contrast to the average length of stay for all causes, which 
remained stable (Figure 2.8). 
 
Note: Asthma separations relate to separations where asthma was the principal diagnosis. Asthma was classified according to the International 
         Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM) 7th edition  
         (NCCH 2010a) for 2010–11, and earlier editions were used for the years 1998–99 to 2009–10. In all editions of ICD-10-AM used, the codes  
         for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 2.8: Average length of hospital stay for asthma and all causes, 1998–99 to 2010–11 
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Seasonal variation 
Analysis of the seasonal variation in asthma hospitalisations provides information about the 
periods in the year when more hospital resources may be required, and may also provide 
insight into the factors that contribute to the asthma exacerbations that require 
hospitalisation. 
Among adults, hospitalisation rates for asthma are highest in the winter months and early 
spring, particularly among those aged 65 and over (Figure 2.9). This may reflect the increase 
in respiratory infections (such as cold and flu) in winter.  
A similar trend has been observed among Canadian adults where hospitalisations for asthma 
are at their highest levels during the winter months, particularly shortly after Christmas 
(Johnston 2007).  
Among children, the peaks for hospitalisations attributed to asthma occur in late summer 
and autumn (Figure 2.9). The reason for these seasonal peaks may be related to a high 
incidence of respiratory infections in children related to the return to school after the 
holidays or, alternatively, to seasonal variations in air pollution.  
Studies conducted overseas have also observed increased asthma hospitalisation rates in 
children in early autumn, with consistent timing after school holidays (Johnston 2007; 
Johnston et al. 2005; Van Dole et al. 2009). A Canadian study reported large peaks of 
hospitalisation for asthma 2 to 3 weeks after school return from summer vacation in Canada, 
Sweden, England and Scotland. Similar seasonal patterns of hospitalisation for asthma have 
been observed in New Zealand following school return after summer vacation (Johnston & 
Sears 2006).  
The post-summer holiday peak for asthma among children may be related to viral infections 
and allergen exposure, perhaps enhanced by the increase in social contacts at this time 
(Lincoln et al. 2006) and reduced compliance with asthma treatment during the summer 
period (Spahn et al. 2009; Van Dole et al. 2009). Other factors have been considered, 
including weather changes and airborne pollutants.  
Seasonal weather variation differs across Australia: from southern Australia where there are 
distinctive seasonal changes to the tropical north where the four seasons are less well 
defined. As the majority of Australia’s population live in regions where there are distinct 
seasons, the trends in Figure 2.9 are likely to reflect this experience. 
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Notes 
1.        Data are for admissions (not separations). 
2.        Data are averaged over two calendar years: 2009 and 2010. 
3.        Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases and Related  
Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 7th edition (NCCH 2010a) for 2010–11, and the 6th edition was used  
for the years 2008–09 and 2009–10. In both editions of ICD-10-AM used, the codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 2.9: Seasonal variation in hospital admission rates for asthma, 2009–2010 
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3 Asthma comorbidities  
Comorbidities when asthma is the principal 
diagnosis 
The presence of one or more additional health conditions (comorbid conditions) in people 
with asthma is a common occurrence and can complicate the management of the disease and 
compromise quality of life. This section investigates the presence of comorbidities in people 
hospitalised with a principal diagnosis of asthma.  
In the NHMD, an additional diagnosis is a condition or complaint that either coexists with 
the principal diagnosis or arises during the episode of care. Additional diagnoses are 
recorded if the conditions affect patient management. In this section additional diagnoses are 
used as a measure of comorbidities. 
It is important to note that the comorbidity information in this section is likely to under-
represent the prevalence of the comorbid conditions because only conditions which affect the 
care of the hospitalised patients are recorded in the NHMD.  
In 2010–11, 41% of patients hospitalised with a principal diagnosis of asthma had at least one 
comorbidity recorded during their hospital stay. The proportion of patients hospitalised for 
asthma with at least one comorbidity increased with age from 37% among those aged 0–14 to 
59% among those aged 65 and over (Table 3.1). More females (45%) than males (38%) 
hospitalised for their asthma had at least one comorbid condition. 
The presence of comorbidity is associated with a longer length of stay in hospital. In 2010–11 
the average length of stay for asthma was 2.7 days among those with at least one 
comorbidity compared with 1.5 days for those with no comorbidity. 
Table 3.1: Comorbidities in people hospitalised with asthma, 2010–11 
 0–14  
years 
15–34  
years 
35–64  
years 
65 years  
and over 
All ages 
Comorbidity Proportion of all asthma separations (%) 
Acute respiratory infections 26.0 22.6 22.5 24.3 24.7 
Other upper respiratory conditions 0.3 0.7 1.6 1.5 0.7 
COPD 0.0 0.4 1.4 1.7 0.5 
Bronchiectasis 0.0 0.4 0.7 2.1 0.4 
Any respiratory disease 27.3 27.0 29.0 31.9 28.0 
Any endocrine, nutritional or metabolic disease 1.7 7.8 12.1 15.1 5.9 
Any circulatory disease 0.2 1.5 5.4 19.2 3.2 
Any comorbidity 36.6 39.2 47.6 58.7 41.3 
Notes 
1. Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases and Related 
Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 7th edition (NCCH 2010a). The codes for asthma were J45 and J46.  
2. Comorbidities were classified using ICD-10-AM as follows: acute respiratory infections (J00–J22); chronic obstructive pulmonary disease 
(COPD) (J40–J44); bronchiectasis (J47); other upper respiratory conditions (includes allergic rhinitis, chronic sinusitis, chronic laryngitis) 
(J30–J39); any respiratory disease (J00–J99); any endocrine, nutritional or metabolic disease (includes diabetes) (E00–E89); any circulatory 
disease (I00–I99).  
Source: AIHW National Hospital Morbidity Database. 
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Respiratory comorbidities 
Acute respiratory infections occurred frequently as an additional diagnosis for children and 
adults hospitalised with asthma. Approximately one in four people hospitalised with a 
principal diagnosis of asthma in 2010–11 in all age groups (23–26%) had an acute respiratory 
infection recorded as an additional diagnosis (Table 3.1; See Box 2 for a brief description of 
key respiratory conditions presented in Table 3.1). 
As not all cases of respiratory infection may be reported, for example because they have 
resolved before the hospital admission, it is likely that these data under-represent the role of 
respiratory infections as triggers for exacerbations leading to hospitalisation. Prospective 
studies have indicated that respiratory viral infections are associated with around 80% of 
asthma exacerbations in children (Johnston et al. 1995) and up to 75% in adults (Wark et al. 
2002). 
Other obstructive lung disease often coexists with a diagnosis of asthma, particularly among 
older people. Among people aged 65 and over who were hospitalised with asthma, 
approximately 2% had COPD and 2% had bronchiectasis as reported comorbid conditions 
(Table 3.1).  
Box 2: Respiratory conditions  
 Acute respiratory conditions include the common cold, influenza (a viral infection 
characterised by fever, sore throat, muscle pains, headache and cough), bronchitis 
(inflammation of the airways leading to cough and phlegm production), sinusitis 
(inflammation of the sinus cavities) and laryngitis (inflammation of the larynx, or 
‘voice box’). 
 Other upper respiratory conditions include allergic rhinitis (hay fever), chronic 
sinusitis and chronic laryngitis. 
 Chronic obstructive pulmonary disease (COPD) includes emphysema (a long-term 
lung disease) and chronic bronchitis. 
 Bronchiectasis is a condition characterised by an abnormal widening of the lungs’ air 
passages. This allows infections to start. It has a number of causes, including cystic 
fibrosis, low antibody levels and infections such as tuberculosis, whooping cough and 
measles. 
Other comorbidities 
Among young adults aged 15–34 who were hospitalised with asthma, endocrine, nutritional 
and metabolic diseases (such as diabetes) were common comorbidities (8%). The prevalence 
of these diseases as an additional diagnosis increased with age, to 12% for those aged 35–64, 
and 15% among those aged 65 and over. Circulatory diseases were a particularly common 
comorbidity among those aged 65 and over, with 19% of asthma separations having a 
circulatory disease listed as an additional diagnosis (Table 3.1). 
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Principal diagnoses when asthma is an additional 
diagnosis 
In addition to the 37,830 hospitalisations in 2010–11 where asthma was the principal 
diagnosis, asthma was an additional diagnosis in 15,547 hospital separations.  
For patients with an additional diagnosis of asthma in 2010–11, the most common principal 
diagnosis was acute respiratory infection, including influenza and bronchitis (ICD-10-AM 
codes J00–J22) (See Box 2). Separations with this principal diagnosis accounted for 31% of 
separations where asthma was recorded as an additional diagnosis.  
The most common principal diagnosis associated with an additional diagnosis of asthma 
among people aged 0–14 and 35 and over was an acute respiratory infection.  
Among people aged 15–34 the most common principal diagnoses associated with an 
additional diagnosis of asthma were pregnancy, childbirth and puerperium (the six weeks 
after childbirth) (ICD-10-AM codes O00–O99). Separations with these principal diagnoses 
accounted for 40% of separations where asthma was recorded as an additional diagnosis. 
Presumably, this reflects the relative importance of these conditions as causes of 
hospitalisation in this age group.  
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4 Invasive mechanical ventilation 
A small proportion of people with severe exacerbations of asthma either stop breathing 
altogether or decrease their breathing to such an extent that they are at risk of stopping 
breathing. This represents a severe, imminently life-threatening event which can only be 
averted by the introduction of artificial mechanical ventilation via an endotracheal tube 
(‘breathing tube’) attached to a positive pressure ventilator, otherwise known as a ‘life 
support machine’. This procedure is sometimes referred to as invasive mechanical 
ventilation to distinguish it from non-invasive forms of ventilation used in less severe 
circumstances. Both invasive and non-invasive mechanical ventilation are also referred to as 
‘assisted ventilation’. 
Information about invasive mechanical ventilation provides insights into the prevalence of 
severe, life-threatening asthma. This section presents data relating to the use of invasive 
mechanical ventilation among patients with a principal diagnosis of asthma. A list of all the 
procedure codes included in these analyses is provided in Appendix A, Section A.2.1. 
Between 2005–06 and 2010–11, invasive mechanical ventilation occurred in 1,554 hospital 
separations with a principal diagnosis of asthma.  
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Population subgroups 
Age and sex 
The rate of hospital separations for asthma that were associated with provision of invasive 
mechanical ventilation was highest among young and middle-age adults and lowest for 
children. Patients aged 65 and over were less likely than those aged 15–64 to have undergone 
invasive mechanical ventilation during an asthma hospitalisation (Figure 4.1).  
Among children, the rate of invasive mechanical ventilation did not differ between boys and 
girls. Above the age of 15, the rate of invasive mechanical ventilation was higher for males 
than females (Figure 4.1). 
 
Note: Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases and Related 
         Health Problems, 10th Revision, Australian Modification (ICD-10-AM) 7th edition (NCCH 2010a) for 2010–11, and earlier editions were used  
         for the years 2005–06 to 2009–10. In all editions of ICD-10-AM used, the codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 4.1: Rate of hospital separations for asthma with invasive mechanical ventilation, 2005–06 to 
2010–11 
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Country of birth 
People aged 15 and over born in a non-English-speaking country were more likely to have 
invasive mechanical ventilation during a hospital separation for asthma than those of the 
same age who were born in an English-speaking country (Figure 4.2). This may reflect more 
severe disease or, possibly, delayed implementation of effective treatment for exacerbations 
in adults who were born in a non-English-speaking country. 
 
Notes 
1. English-speaking countries cover Australia, New Zealand, Canada, United Kingdom, Ireland, United States of America, South Africa and 
Zimbabwe. Non-English-speaking countries cover all other countries. 
2. Information was not presented for ages 0–14 due to small numbers.  
3. Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases and Related 
Health Problems, 10th Revision, Australian Modification (ICD-10-AM) 7th edition (NCCH 2010a) for 2010–11, and earlier editions were used 
for the years 2005–06 to 2009–10. In all editions of ICD-10-AM used, the codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 4.2: Rate of hospital separations for asthma with invasive mechanical ventilation, by country 
of birth, 2005–06 to 2010–11 
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Trends over time 
For those aged 15 and over, there were fluctuations in the rate of invasive mechanical 
ventilation between 2000–01 and 2010–11, with an overall decline from 15.4 to 12.2 
ventilations per 1,000 separations for asthma (Figure 4.3). Over the same period, there was 
little change in the proportion of separations for children aged 0–14 who received invasive 
mechanical ventilation during a hospital stay for asthma, with a rate of 1.1 ventilations per 
1,000 separations for asthma in 2000–01 and 1.8 ventilations per 1,000 separations for asthma 
in 2010–11 (Figure 4.3). This observed trend for children needs to be treated with caution as 
the provision of mechanical ventilation for this age group was so infrequent.  
 
Note: Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases and Related 
         Health Problems, 10th Revision, Australian Modification (ICD-10-AM) 7th edition (NCCH 2010a) for 2010–11, and earlier editions were used  
         for the years 2000–01 to 2009–10. In all editions of ICD-10-AM used, the codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Figure 4.3: Proportion of hospital separations for asthma with invasive mechanical ventilation, 
2000–01 to 2010–11 
The decrease in the asthma hospitalisation rate over this time period (Figure 2.7) led to a 
decrease in the rate of ventilations per population for those aged 15 and over. For this age 
group, the age-standardised rate of invasive mechanical ventilation declined from 2.3 per 
100,000 population in 2000–01 to 1.1 per 100,000 in 2010–11. For children aged 0–14 the age-
standardised rate of invasive mechanical ventilation showed little variation over the same 
time period, with a rate of 0.7 per 100,000 population in 2000–01 and 0.9 per 100,000 
population in 2010–11. As previously mentioned, this observed trend for children needs to 
be treated with caution as the provision of mechanical ventilation for this age group was so 
rare. 
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5 Health expenditure on asthma  
Estimating health expenditure on asthma 
Direct health expenditure is a term used to describe the amount spent on health care 
services. In this report, data from the AIHW Disease Expenditure Database 2008–09 are used 
to describe direct health expenditure for asthma and all conditions in Australia. This 
database contains estimates of expenditure by disease category, age group and sex for 
hospital admitted patient services, out-of-hospital medical services, prescription 
pharmaceuticals and ‘other’ expenditure (See Box 3 for more detailed information about each 
category of expenditure).  
Box 3: Health sectors in the Disease Expenditure Database 2008–09 
 ‘Hospital admitted patient services’ comprises expenditure on public and private 
hospital services for admitted patients (same-day as well as overnight admissions). 
This category also includes expenditure for medical services provided to private 
admitted patients in hospitals. 
 ‘Out-of-hospital medical services’ comprises expenditure on care in the community 
from General Practitioners as well as specialists, and from imaging and pathology 
services. Specifically, it includes Medicare Benefits Scheme (MBS) unreferred 
attendances, imaging, pathology, specialist, other medical MBS and any other medical 
services expenditure for 2008–09 that has not been counted elsewhere. 
 ‘Prescription pharmaceuticals’ includes expenditure on benefit paid pharmaceuticals 
(Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits 
Scheme (RPBS) pharmaceuticals); under co-payment prescriptions; and private 
prescriptions. 
 ‘Other’ expenditure comprises expenditure on optometrical services, dental, 
community mental health and public health cancer screening. The category ’other’ is 
not applicable for asthma but is applicable for total recurrent health expenditure. 
The method used in estimating the direct health expenditure in the AIHW Disease 
Expenditure Database is generally a ‘top–down’ approach (except in the case of hospital 
admitted patient services data) where total expenditure across the health system is estimated 
and then allocated to the relevant conditions. Although this method yields consistency, good 
coverage, and totals that add up to known expenditures, it is not as sensitive or accurate for 
any specific disease as may be provided by a detailed ‘bottom–up’ analysis of actual costs 
incurred by patients with that disease.  
A ‘bottom-up’ approach in allocating disease expenditure, however, faces several practical 
difficulties. For example, expenditure, such as capital expenses or expenses for general aids 
and medical appliances, cannot be attributed to specific conditions. There is also a lack of 
available data that would enable linkage of broad expenditure costs to a particular disease 
for items such as over-the-counter pharmaceuticals and non-admitted patient services. In the 
AIHW Disease Expenditure Database 2008–09, expenditure that was not able to be allocated 
by disease includes: capital expenditure; non-admitted patient hospital services; over-the-
counter drugs; other health practitioner services (except optometry); community health 
services expenditure (except community mental health); expenditure on public health 
programs (except cancer screening programs); health administration; health aids and 
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appliances; and patient transport (ambulance). As a result, approximately 70% of total direct 
health expenditure was allocated by disease (AIHW 2010), providing conservative estimates 
of direct expenditure by disease.  
Although it is not without shortcomings, the AIHW Disease Expenditure Database provides 
a broad picture of the use of health system resources classified by disease. AIHW continue to 
improve the methodology used to produce these estimates.  
For more information about the AIHW Disease Expenditure Database, refer to Appendix A, 
Section A.2.3, and the data quality statement available at: 
<http://meteor.aihw.gov.au/content/index.phtml/itemId/512599>. 
Direct health expenditure on asthma 
In 2008–09, estimated direct health expenditure attributable to asthma was $655 million, 
accounting for 0.9% of total allocated health expenditure in that year.  
Approximately $128 million of estimated direct health expenditure attributable to asthma 
was for admitted patient hospital care. The pattern of expenditure on asthma differs 
somewhat to the pattern for diseases overall. A substantially lower proportion of asthma 
expenditure was attributed to admitted patient hospital care (20%) compared with total 
recurrent health expenditure across all diseases (52%). Half (50%) of all asthma expenditure 
in 2008–09 was attributed to prescription pharmaceuticals, compared to 14% across all 
diseases (Figure 5.1, Appendix table B.5). This is consistent with the fact that asthma is a 
condition predominantly treated and managed in the community through primary health 
care and medication use. 
 
Figure 5.1: Allocated asthma expenditure and total recurrent health expenditure, by sector, 2008–09 
Note: Refer to Box 3 for more information on the health sectors. 
Source: AIHW disease expenditure database. 
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participation and costs incurred by families and carers of people with asthma, are not 
reflected in the direct health expenditure estimates. At present, there are little data on these 
other aspects of the economic burden of asthma. 
One alternative approach to quantifying the economic impact of asthma, and of other 
diseases more broadly, is the ‘burden of disease’ approach, which was used in the Global 
Burden of Disease Study (IHME 2013). In this approach, the impact of disease is quantified in 
terms of impact on survival (measured by ‘years of life lost’) and impact on functional 
capacity (measured by ‘years of life disabled’). The combined effect of both of these impacts 
is summarised as disability-adjusted life years (DALYs), which quantify the burden 
attributable to a specific disease. One DALY represents one year of lost ‘good health’. It is a 
summary measure that reflects the overall impact of a particular disease due to morbidity 
and mortality (Mathers et al. 1999). 
In 2003, asthma was estimated to account for 2.4% of the total disease burden in Australia as 
measured by DALYs (Begg et al. 2007, AIHW: ACAM 2009).  
Latest estimates from the 2010 Global Burden of Disease Study showed that, worldwide, 
asthma accounted for 2.3% of years lived with disability attributable to non-communicable 
diseases (Vos et al. 2012) and 1.7% of DALYs attributable to non-communicable diseases 
(Murray et al. 2012).  
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Appendix A: Methods and data sources  
This appendix provides information on the methods and data sources used in this report. 
Information is provided about the population subgroup analysis. 
A.1 Analysis methods  
A.1.1 Rates  
In this report, rates per 100,000 population per year were calculated, using relevant ABS 
Estimated Resident Population (ERP) data. 
Data from the NHMD cover financial year periods. For analysis in this report, the 30 June 
denominator population at the start of the financial year was used.  
For analysis of seasonality, the weekly admission rates were calculated for 2009, using the 30 
June 2009 population as the denominator, and for 2010, using the 30 June 2010 population as 
the denominator. The results for these two years were then averaged. 
 
Age-standardised rates  
Age-standardised rates were used in this report to adjust for differences in population age 
structures when comparing rates for different periods of time, or for population subgroups. 
Direct age-standardisation was used.  
Age-standardised rates were calculated using the following formula: 
Age standardised rate (ASR) = (ri Pi)/Pi   
Where: 
ri   is the sex- and age-group specific rate for sex and age group i in the population 
being studied 
Pi  is the population of age group i in the standard population 
The Australian population as at 30 June 2001 was the standard population in all analyses 
(ABS 2008). 
A.1.2 Exclusions 
In all analysis presented in this report, separations were excluded if care type was coded as 
7.3 (Newborn with no qualified days), 9 (Posthumous organ procurement) or 10 (Hospital 
boarder). 
Separations were excluded from the analysis if age was not reported. 
Separations where sex was unspecified were included, unless the data were broken down by 
sex, in which case separations where sex was unspecified were excluded. Separations where 
sex was unspecified cover separations where sex was indeterminate, not stated or 
inadequately described.  
In the country of birth analysis, country of birth code 0 was not defined, and was therefore 
excluded from the analysis. This affected 0.05% of asthma hospitalisations. 
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In the analysis of additional diagnoses (when asthma was the principal diagnosis), the 
following additional diagnoses were excluded: 
• symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified 
(R00–R99) 
• injury, poisoning and certain other consequences of external causes (S00–T98) 
• factors influencing health status and contact with health services (Z00–Z99) 
• codes for special purposes (U00–U99). 
A.2 Data sources 
A.2.1 Hospital data 
The National Hospital Morbidity Database (NHMD) contains data on episodes of care for 
patients admitted to hospital, including demographic, procedural and length-of-stay 
information. Public and private hospitals provide data for hospital separations to state and 
territory health authorities which are then provided to AIHW for inclusion in the NHMD. 
The data are collated in financial year periods.  
The hospital separations data do not include episodes of non-admitted patient care provided 
in emergency departments or outpatient clinics. Patients in these settings may be admitted 
subsequently, with the care provided to them as admitted patients being included in the 
NHMD. 
It should be noted that the data analysed for this report are based on episodes and not 
individuals and, hence, may include multiple episodes for the same person.  
For the analysis of the average length of stay in hospital, a same-day patient is allocated a 
length of stay of one day. The length of stay for an overnight patient is calculated by 
subtracting the date the patient is admitted from the date of separation and deducting days 
the patient was on leave.  
A data quality statement for the NHMD for 2010–11 can be found at: 
<http://meteor.aihw.gov.au/content/index.phtml/itemId/511338>.  
Hospital diagnosis codes 
Principal and additional diagnoses were coded using the International Statistical 
Classification of Diseases and Related Health Problems, 10th Revision, Australian 
Modification (ICD-10-AM), 7th edition (NCCH 2010a) for 2010–11, and earlier editions were 
used for the years 1998–99 to 2009–10.  
Mechanical ventilation  
Procedures were recorded using the seventh edition of the Australian Classification of 
Health Interventions (ACHI) (NCCH 2010b). 
The procedure codes based on ACHI that have been included in these analyses are: 
• Invasive ventilation 
– 13882-00—Management of continuous ventilatory support ≤24 hours 
– 13882-01—Management of continuous ventilatory support >24 hours <96 hours  
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– 13882-02—Management of continuous ventilatory support ≥96 hours 
– 13857-00—Continuous ventilatory support, initiation outside of ICU 
– 13879-00—Continuous ventilatory support, initiation in ICU 
A.2.2 Population data 
This report uses population data sourced from the ABS. These population estimates are 
referred to as estimated resident populations. 
The estimated resident populations used in this report are based on the 2006 Census of 
Population and Housing. The ABS collects the Census data and makes the following 
adjustments: 
 All respondents in the census are placed in their state/territory, SLA, and postcode of 
usual residence. Overseas visitors counted in the census are excluded. 
 An adjustment is made for people missed in the census (approximately 2%). 
 Australians temporarily overseas on census night (these are not counted in the census) 
are added to the usual residence census count adjusted for undercount. 
Estimated resident populations are then updated each year from the census date using 
indicators of population change such as births, deaths and net migration. More information 
is available from <www.abs.gov.au>. 
A.2.3  Expenditure data 
Expenditure data used in this report were obtained from the Australian Institute of Health 
and Welfare’s Disease Expenditure Database. This report considers recurrent health 
expenditure that has been allocated by health sector and disease.  
The expenditure that was not able to be allocated by disease includes capital expenditure, 
non-admitted patient hospital services, over-the-counter drugs, all other health practitioner 
services excluding optometry, community health expenditure (except community mental 
health), expenditure on public health programs (except cancer screening programs), health 
administration, health aids and appliances and research.  
Estimates in the AIHW Disease Expenditure Database are derived by combining information 
from the National Hospital Morbidity Database, the National Public Hospital Establishments 
Database, the Health Expenditure Database, the National Hospital Cost Data Collection and 
the Bettering the Evaluation and Care of Health survey of General Practice activity. 
A data quality statement for the AIHW Disease Expenditure Database, 2008–09, can be found 
at:  <http://meteor.aihw.gov.au/content/index.phtml/itemId/512599>. 
A.3 Population subgroup analysis  
Aboriginal and Torres Strait Islander Australians  
‘Indigenous Australians’ refers to people who identify themselves as being of Aboriginal or 
Torres Strait Islander origin. In this report information about hospitalisations among 
Indigenous Australians was compared with that for ‘Other Australians’, a category covering 
non-Indigenous Australians, as well as those whose Indigenous status was not stated.  
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Hospitalisation data from all states and territories were used in this analysis. This approach 
was recommended in the report ‘Indigenous identification in hospital separations data: 
Quality report’ (AIHW 2013).  
An estimated 88% of Indigenous patients were correctly identified in Australian public 
hospital admission records in 2011–12 (AIHW 2013). This is one year after the analysis 
presented here. 
The population counts used in this analysis were drawn from the experimental projections, 
series B, calculated by the ABS (ABS 2009b).  
Country of birth 
The Department of Immigration and Multicultural and Indigenous Affairs (DIMIA) 
developed a classification from 1996 census data, which places every country into one of four 
groups based on the relative English proficiency of recent arrivals to Australia (DIMA 2001).  
In this report the category ‘English-speaking countries’ correspond to countries in the DIMIA 
English proficiency group 1, namely Australia, New Zealand, the United Kingdom, Ireland, 
the United States of America, Canada, Zimbabwe or South Africa. These are the main 
countries from which Australia receives overseas settlers who are likely to speak English. 
‘Non-English-speaking countries’ cover all other countries. This corresponds to the DIMIA 
English proficiency countries in the remaining groups 2 to 4.  
Socioeconomic status  
The SEIFA Index of Relative Socio-economic Disadvantage (IRSD) is one of five indexes 
developed by the ABS to measure socioeconomic characteristics associated with geographic 
locations (ABS 2006a), based on information from the Australian Census of Population and 
Housing. Each index summarises information relating to a variety of social and economic 
characteristics associated with families and households, personal education qualifications 
and occupation.  
This report uses the SEIFA IRSD index as it provides a summary score for a range of key 
socioeconomic variables that are related to health status, including household income and 
resources; education; occupation; fluency in English; and Indigenous status. The index is 
constructed so that relatively advantaged areas have high index values. 
Individual records were classified into quintiles of socioeconomic status according to the 
SEIFA index value associated with the Statistical Local Area (SLA) of usual residence of the 
patient. The quintiles were calculated using the population-based method, so that each 
quintile will contain approximately 20% of the population. Quintile 1 (SES 1) includes 
households with the lowest socioeconomic status and quintile 5 (SES 5) includes households 
with the highest socioeconomic status.  
It is important to note that the index reflects the relative disadvantage of all people living in 
an area, not of an individual. Therefore, this measure probably under-represents the true 
inequality in health at the individual level. 
Cities, regional and remote areas  
This report uses the remoteness classification based on the 2006 Australian Standard 
Geographical Classification (ASGC). The ASGC was derived by the ABS from information 
collected in the 2006 Census of Population and Housing. The remoteness classification uses 
Accessibility/Remoteness Index of Australia (ARIA) scores to determine remoteness areas. 
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This index is calculated based on how distant a place is by road from urban centres of 
varying sizes, and therefore provides a relative indication of how difficult it might be for 
residents to access certain services, such as health care and education (ABS 2006c). 
Individual hospitalisation records were classified according to the ASGC remoteness level 
associated with the SLA of usual residence of the patient. 
There are five remoteness areas in this classification: Major cities, Inner regional, Outer regional, 
Remote and Very remote (ABS 2006c). 
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Appendix B: Additional tables 
Table B.1 Hospital separations for asthma per 100,000 population, 2010–11  
 
0–4 years 5–14 years 15–34 years 35–64 years 65 years and over All ages 
Males 1,230 325 60 53 67 172 
Females 673 223 107 126 160 175 
Persons 958 275 83 90 117 175 
Notes: 
1. Age-standardised to the Australian population as at 30 June 2001. 
2. Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases  
and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 7th edition (NCCH 2010a). The codes for  
asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
Table B.2 Hospital separations for asthma and all causes per 100,000 population, 1998–99 to 
2010–11 
 Asthma  All causes 
 
0–14 years 
15 years 
 and over All ages  0–14 years 
15 years 
 and over All ages 
1998–99 738 167 284   13,853   35,583   31,120  
1999–00 579 161 247   13,664   36,105   31,496  
2000–01 653 152 255   13,622   37,142   32,312  
2001–02 525 130 211   13,796   37,910   32,957  
2002–03 482 115 191   13,668   38,801   33,639  
2003–04 502 113 193   13,661   39,311   34,043  
2004–05 518 104 189   13,235   39,812   34,354  
2005–06 535 101 190   13,393   40,761   35,140  
2006–07 522 92 181  13355 41654  35,842  
2007–08 524 95 183  13632 42230  36,357  
2008–09 515 87 175  13624 42857  36,853  
2009–10 548 90 184  13527 44004  37,744  
2010–11 495 92 175   13,580   44,819   38,403  
Notes: 
1. Age-standardised to the Australian population as at 30 June 2001.  
2. Asthma hospital separations relate to separations where asthma was the principal diagnosis. Asthma was classified according to the 
International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM)  
7th edition (NCCH 2010a) for 2010–11, and earlier editions were used for the years 1998–99 to 2009–10. In all editions of ICD-10-AM  
used, the codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
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Table B.3: Hospital separations for asthma per 100,000 population, by  
Indigenous status, 2010–11  
 
Indigenous Other Australians All Australians 
0–4 965 958 958 
5–14 370 271 275 
15–34 167 81 83 
35–54 442 82 89 
55 and over 340 105 108 
All ages 366 171 175 
Notes 
1. Age-standardised to the Australian population as at 30 June 2001.  
2. Other Australians include people classified as non-Indigenous plus those for whom Indigenous status  
was not reported. Indigenous status was not reported in 1.2% of hospital separations in the Other  
Australians category. For more information on Indigenous identification data see Appendix A, Section A.2. 
3. Asthma was the principal diagnosis. Asthma was classified according to the International Statistical  
Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification  
(ICD-10-AM), 7th edition (NCCH 2010a). The codes for asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
 
Table B.4: Number of hospital separations for asthma by Indigenous status 
Age group (years) Indigenous Not Indigenous Not stated All Australians 
0–4 667 12,981 169 13,817 
5–14 477 6,942 84 7,503 
15–34 312 4,771 60 5,143 
35–54 526 4,896 52 5,474 
55 and over 180 5,633 80 5,893 
All ages 2,162 35,223 445 37,830 
Notes 
1. For more information on Indigenous identification data see Appendix A, Section A.2. 
2. Asthma was the principal diagnosis. Asthma was classified according to the International Statistical Classification of Diseases and  
Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM), 7th edition (NCCH 2010a). The codes for  
asthma were J45 and J46.  
Source: AIHW National Hospital Morbidity Database. 
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Table B.5: Allocated asthma expenditure and total recurrent health  
expenditure, by sector, 2008–09 
  Asthma expenditure 
 
Total recurrent health 
expenditure 
Health sector $ (million) Per cent 
 
$ (million) Per cent 
Prescription pharmaceuticals  328 50.1 
 
10,583 14.2 
Out-of-hospital medical expenses 198 30.3 
 
15,871 21.4 
Admitted patients 128 19.6 
 
38,675 52.1 
Other - - 
 
9,116 12.3 
Total allocated expenditure 655 100.0 
 
74,245 100.0 
Note: Refer to Chapter 5, Box 3 for more information on the health sectors. 
Source: AIHW Disease Expenditure Database. 
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Glossary 
Additional diagnosis In the NHMD, an additional diagnosis is a condition or 
complaint that either coexists with the principal diagnosis or 
arises during the episode of care. Additional diagnoses are 
recorded if the conditions affect patient management 
Age-standardisation A method of removing the influence of age when comparing 
populations with different age structures. 
Comorbidity When a person has two or more health problems at the same 
time. 
Hospital separation An episode of admitted patient care, which can be a total hospital 
stay (from admission to discharge, transfer or death) or a portion 
of a hospital stay beginning or ending in a change of type of care 
(for example, from acute care to rehabilitation). 
Incidence The number of new cases (of a disease, condition or event) in a 
population in a given time period 
Indigenous Australians People who identify themselves as being of Aboriginal or Torres 
Strait Islander origin. 
Other Australians A category covering non-Indigenous Australians, as well as those 
whose Indigenous status was not stated. 
Prevalence The number or proportion (of a disease, condition or event) 
present in a population at a given time. 
Principal diagnosis In the NHMD, the diagnosis established, after study, to be chiefly 
responsible for occasioning the patient’s episode of admitted 
patient care. 
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Asthma hospitalisations in Australia 
2010–11
This report provides an overview of hospitalisation 
patterns over time and across population groups. 
Asthma hospitalisation rates decreased between  
1998–99 and 2010–11, by 33% for children and  
45% for adults. The rate of hospitalisation for asthma 
among Indigenous Australians was 2.1 times the rate  
for Other Australians. Asthma hospitalisation rates  
were also higher for people living in areas with  
lower socioeconomic status.
